CR6434A - AMINOTRANSPHERASE DEPENDENT ON AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY - Google Patents

AMINOTRANSPHERASE DEPENDENT ON AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY

Info

Publication number
CR6434A
CR6434A CR6434A CR6434A CR6434A CR 6434 A CR6434 A CR 6434A CR 6434 A CR6434 A CR 6434A CR 6434 A CR6434 A CR 6434A CR 6434 A CR6434 A CR 6434A
Authority
CR
Costa Rica
Prior art keywords
diabetic retinopathy
dependent
treatment
aminotranspherase
amino acids
Prior art date
Application number
CR6434A
Other languages
Spanish (es)
Inventor
Stephen Bryans Justin
Yen Hu Lain
M Hutson Susan
Foley Lanoue Kathryn
Lieth Erich
Francis Rafferty Michael
Robert Ryder Todd
Zhi Su Ti
Franklin Welty Devin
Juergen Wustrow David
Original Assignee
Univ Wake Forest
Penn State Res Found
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest, Penn State Res Found, Warner Lambert Co filed Critical Univ Wake Forest
Publication of CR6434A publication Critical patent/CR6434A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se relaciona con un método para el tratamiento profiláctico y terapéutico de la retinopatía diabética, incluyendo el tratamiento en la etapa de la retinopatía prediabética, la etapa de la retinopatía diabética no proliferativa y la etapa de la retinopatía diabética proliferativa. El método comprende la administración de un inhibidor de la vía de la aminotransferasa dependiente de aminoácidos ramificados. Preferentemente, el inhibidor de la vía de la amino transferasa dependiente de los aminoácidos de cadena ramificada (BCAT) es un compuesto de las Fórmulas I, II y/o III.The present invention relates to a method for the prophylactic and therapeutic treatment of diabetic retinopathy, including treatment at the stage of prediabetic retinopathy, the stage of non-proliferative diabetic retinopathy and the stage of proliferative diabetic retinopathy. The method comprises the administration of a branched amino acid-dependent aminotransferase pathway inhibitor. Preferably, the branched chain amino acid-dependent amino transferase pathway (BCAT) inhibitor is a compound of Formulas I, II and / or III.

CR6434A 1999-12-08 2001-08-07 AMINOTRANSPHERASE DEPENDENT ON AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY CR6434A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16963599P 1999-12-08 1999-12-08

Publications (1)

Publication Number Publication Date
CR6434A true CR6434A (en) 2004-04-27

Family

ID=27757245

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6434A CR6434A (en) 1999-12-08 2001-08-07 AMINOTRANSPHERASE DEPENDENT ON AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY

Country Status (2)

Country Link
CR (1) CR6434A (en)
ZA (1) ZA200106260B (en)

Also Published As

Publication number Publication date
ZA200106260B (en) 2002-10-30

Similar Documents

Publication Publication Date Title
DK0942751T3 (en) Preparations for the treatment of peripheral neuropathies containing antidepressants and / or monoamine oxidase inhibitors and / or vitamin B12 and / or precursor to or induce a neurotransmitter
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
IT1312377B1 (en) COMPOSITIONS BASED ON TIOTIC ACID, CISTEIN AND / OR N-ACETYL CISTEINADA USE IN PHARMACEUTICAL, DIETETIC AND COSMETIC PREPARATIONS
DK1039895T3 (en) Use of 3-Benzoylphenylacetic Acids, Esters or Amides to Treat GLC1A Glaucoma
ECSP11005768A (en) CONDENSED AZOL-PYRIMIDINE DERIVATIVES
ATE344029T1 (en) TREATING TYPE II DIABETES WITH DIPEPTIDYL PEPTIDASE IV INHIBITORS
SE9704870D0 (en) New pharmaceutical formulation I
TR200103493T2 (en) Metalloprotease inhibitors
ES2144119T3 (en) USE OF NON-STEROID CYCLOOXYGENASE INHIBITORS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HIGH INTRAOCULAR PRESSURE.
BR9811099A (en) Urokinase inhibitors
UY26474A1 (en) AMINO ACID DEPENDENT INHIBITORS FOR BRANCHED CHAIN AMINO ACIDS, AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY.
DK0699439T3 (en) Treatment of diseases caused by sebaceous glands with acyl-CoA-cholesterolacyltransferase inhibitors
NO20051654L (en) Prolonged release of pharmaceutical preparation
DK1091733T3 (en) (-) - Pseudoephedrine as a sympathomimetic drug
ATE395061T1 (en) TOPICAL COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF NIACIN PRODRUGS AND METHODS FOR TREATING HYPERLIPIDEMIA
DK0966283T3 (en) Pharmaceuticals for the healing and prevention of diseases resulting from damage to vascular endothelial cells
CR6434A (en) AMINOTRANSPHERASE DEPENDENT ON AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY
ES2192263T3 (en) DERIVATIVES OF BENZO (C) QUINOLIZINA, ITS PREPARATION AND EMPLOYMENT AS INHIBITORS OF 5-ALFA-REDUCTASAS.
DK1300143T3 (en) Patches containing 4-biphenylacetic acid
SE0002211D0 (en) Methods and compositions for prevention of myopia
NO20061088L (en) Proton pump inhibitor formulations and methods for the preparation and use of such formulations
DE69828522D1 (en) ANTITROMOMBOTIC AGENTS
DE60112578D1 (en) PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE
ECSP003814A (en) INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY.
ES2136965T3 (en) DERIVATIVES OF 17-HYDROXYIMINOALKYL AND 17-HYDROXYIMINOMETILALQUENIL CICLOPENTANPERHIDROFENANTRENO ACTIVE IN THE CARDIOVASCULAR SYSTEM A PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)